102983645
liked
$Celsius Holdings (CELH.US)$ another trip to 50ma. likely consolidate from there till earnings.
2
9
102983645
liked
$Cassava Sciences (SAVA.US)$ This week finally looks a bit better, keep it up.
Translated
1
102983645
liked
$Upstart (UPST.US)$ has been renouncing from 30 to 47 since September24.
2
3
102983645
liked
$Cassava Sciences (SAVA.US)$ It is unethical and inexcusable what the shorts have done by delaying trials, trying to stop with citizens petition , writing FUD articles and manipulating stock price daily for 3+ years. They failed and must pay for their consequences of the lives they have disrupted from getting a Breakthrough treatment for AD. FDA has always been on SAVÀs side and seen the good effects of treating/repairing misfolded protein. Cassava Sciences (NASDAQ:SAVA - Get Free Report) was up...
3
102983645
liked
3
102983645
liked
$Cassava Sciences (SAVA.US)$
Is it open today?
Is it open today?
Translated
2
102983645
liked
I like to look at the biggest losers
first is it green in the 60 day and YTD columns and what's it's volume (higher volume the better)
If yes then i check out the companies profile (what do they do, what's there competition in that sector like).
After that check out the news, company announcements, ratings, I do all this on moomoo
Then i get on to Google, YouTube, etc, and look for anything that involves the company (there's often articles and videos from other sou...
first is it green in the 60 day and YTD columns and what's it's volume (higher volume the better)
If yes then i check out the companies profile (what do they do, what's there competition in that sector like).
After that check out the news, company announcements, ratings, I do all this on moomoo
Then i get on to Google, YouTube, etc, and look for anything that involves the company (there's often articles and videos from other sou...
10
2
102983645
liked
$Cassava Sciences (SAVA.US)$ proud of you
3
102983645
reacted to
$Cassava Sciences (SAVA.US)$ NEW SAVA BULLISH PRESS RELEASE “Cassava is pleased to put this matter behind us,” Mr. Barry said. “We can now focus all of our attention on completion of the ongoing Phase 3 trials of simufilam. While no one can accurately predict the future, we remain hopeful that the trials will be successful and that, after a rigorous FDA review, simufilam could become available to help those suffering from Alzheimer’s disease.”
4
1